Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Oct 20, 2025 · Filed Oct 21, 2025
TransDigm's Co-Chief Operating Officer sold $1.08M of TransDigm shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,083,180
Shares × reported transaction price
76 days after results of Aug 5, 2025, 23 days before results of Nov 12, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,301.68 on Oct 20, 2025, 6% above its 52-week low and 20% below its high, little changed over the previous 30 trading days
52-week range $1,231.75 (Apr 8, 2025) to $1,620.83 (Jul 30, 2025), 18% of the way up, from 250 adjusted closes. 30 trading days earlier: $1,293.24 on Sep 8, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.1% | +2.9% | −2.8% |
| 30 days | +2.5% | −1.3% | +3.8% |
| 90 days | +10.2% | +1.5% | +8.8% |
| 180 days | −3.0% | +6.1% | −9.1% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
A board member of TransDigm sold $4.87M of TransDigm shares. Nobody planned it ahead of time.
A board member of TransDigm sold $1.15M of TransDigm shares. Nobody planned it ahead of time.